Register Login

HALOZYME THERAPEUTICS, INC. (HALO)

Caudill Cortney 🟡 adjusted position in 28.9K shares (2 derivative) of HALOZYME THERAPEUTICS, INC. (HALO) at $68.25 ($3.4M) Transaction Date: Mar 09, 2026 | Filing ID: 000033

Full text
Register to leave comments
  • News bot March 10, 2026, 11:22 p.m.

    🔍 Caudill Cortney (Executive)

    Company: HALOZYME THERAPEUTICS, INC. (HALO)

    Report Date: 2026-03-09

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 21,546
    • Total shares sold: 50,403

    Detailed Transactions and Holdings:

    • Acquired 20,000 shares of Common Stock at $33.51 per share (Direct)
      Date: 2026-03-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 34,366.00 | transaction_form_type: 4
    • Sold 17,900 shares of Common Stock at $67.751 per share (Direct)
      Date: 2026-03-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 16,466.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,100 shares of Common Stock at $68.252 per share (Direct)
      Date: 2026-03-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 14,366.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 1,546 shares of Common Stock at $33.51 per share (Direct)
      Date: 2026-03-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 15,912.00 | transaction_form_type: 4
    • Sold 8,857 shares of Common Stock at $67.64 per share (Direct)
      Date: 2026-03-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,055.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 20,000 shares of Option to Purchase Common Stock at $33.51 per share (Derivative)
      Date: 2026-03-09 | Code: M | Expires: 2033-11-01 | equity_swap_involved: 0 | shares_owned_after: 69,224.00 | transaction_form_type: 4 | Footnotes: F4
    • Sold 1,546 shares of Option to Purchase Common Stock at $33.51 per share (Derivative)
      Date: 2026-03-10 | Code: M | Expires: 2033-11-01 | equity_swap_involved: 0 | shares_owned_after: 67,678.00 | transaction_form_type: 4 | Footnotes: F4

    Footnotes:

    • F1: Represents a weighted average sales price per share. The shares were sold at prices ranging from $67.210 to $68.195. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
    • F2: Represents a weighted average sales price per share. The shares were sold at prices ranging from $68.210 to $68.320. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
    • F3: Represents a weighted average sales price per share. The shares were sold at prices ranging from $67.520 to $67.785. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
    • F4: Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was November 1, 2023.

Search

News categories